Tweets by IDWeek 2023

Icon Legend

This session is not in your schedule.

This session is in your schedule. Click again to remove it.

Presentation Icons

Live Streamed

On Demand

417 Views

150. HIV: Treatment: Friday, 12:15 - 1:30 p.m.

Poster Session: HIV: Treatment

(1581) Weight and Metabolic Changes with Long-Acting Lenacapavir in a Combination Regimen in Treatment-Naïve People with HIV-1 at Week 80

Friday, October 13, 2023

12:15 PM - 1:30 PM US ET

Location: Hall B + C

Presenting Author(s)

Princy N Kumar, MD

Chief, Infectious Diseases and Travel Medicine
Georgetown University Medical Center
Potomac, Maryland, United States

DG

Deborah A Goldstein, MD

Medical Officer
USAID
Washington DC, District of Columbia, United States
RH

Richard L. Hengel, MD, FIDSA

Partner
Atlanta ID Group
Atlanta, GA, United States
Aditya H Gaur, MD (he/him/his)

Director, Division of HIV and Translational Medicine
St. Jude Children's Research Hospital
Memphis, TN, United States
AW

Anson K Wurapa, MD

Infectious Disease Specialists of Atlanta
Decatur, Georgia, United States
AK

Ann M. Khalsa, MD

Medical Director
Valleywise Health
Phoenix, Arizona, United States
CN

Cheryl L Newman, MD

Medical College of Georgia
Augusta, Georgia, United States
GS

Gary Saunders, BSc

Gilead Sciences Inc
Babraham, England, United Kingdom
SL

Shan-Yu Liu, PhD

Gilead Sciences Inc
Foster City, California, United States
HD

Hadas Dvory-Sobol, PhD

Gilead Sciences
Foster City, California, United States
MR

Martin Rhee, MD

Gilead Sciences
Foster City, California, United States
Samir K. Gupta, MD (he/him/his)

Professor of Medicine
Indiana University School of Medicine
Indianapolis, IN, United States